As of March 2024 Grifols has a market cap of $5.43 Billion. This makes Grifols the world's 2512th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $5.43 B | -47.28% |
2023 | $10.31 B | 46.81% |
2022 | $7.02 B | -36.89% |
2021 | $11.13 B | -36.07% |
2020 | $17.41 B | -17.12% |
2019 | $21.01 B | 31.43% |
2018 | $15.98 B | -12.45% |
2017 | $18.26 B | 44.58% |
2016 | $12.63 B | -10.67% |
2015 | $14.13 B | 9.1% |
2014 | $12.96 B | -13.02% |
2013 | $14.90 B | 44.74% |
2012 | $10.29 B | 113.46% |
2011 | $4.82 B | |
2009 | $3.72 B | 2.04% |
2008 | $3.65 B |
On Mar 27th, 2024 the market cap of Grifols was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $382.60 B | 6,934.61% | ๐บ๐ธ USA |
Amgen AMGN | $152.66 B | 2,706.98% | ๐บ๐ธ USA |
Baxter BAX | $21.78 B | 300.59% | ๐บ๐ธ USA |
Kimberly-Clark KMB | $43.67 B | 703.07% | ๐บ๐ธ USA |